Leuprolide Acetate
14 NDCs across 10 manufacturers|9 Generic,5 Brand
Leuprolide Acetate is used to treat breast neoplasms, endometrial neoplasms, endometriosis, infertility, leiomyoma and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 9, 1985, and the first generic was approved Aug 4, 1998. In 2024, Medicare Part D spent $177 million on Leuprolide Acetate across 41,000 claims for 16,000 beneficiaries.
Leuprolide Acetate is available as 14 NDCs from 10 manufacturers (9 generic, 5 brand), with NADAC prices from $197.61 to $6516.30 per EA — the most expensive product costs about 33× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
14
9G / 5B
Manufacturers
10
competing in market
Price Spread
$197.61 – $6516.30
per EA
7d Activity
avg -0.1% WoW · of 14 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
10 manufacturers producing LEUPROLIDE ACETATE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LUPRON DEPOT 22.5 MG 3MO KIT | $6516.2982 per EA | — |
LUPRON DEPOT 11.25 MG 3MO KIT | $5430.9275 per EA | -0.07% |
LUPRON DEPOT 7.5 MG 1 MONTH KT | $2174.1678 per EA | — |
LUPRON DEPOT-PED 15 MG KIT | $1875.8391 per EA | — |
LUPRON DEPOT 3.75 MG KIT | $1821.1269 per EA | -0.10% |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $261.3184 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $205.7080 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
LEUPROLIDE 2WK 14 MG/2.8 ML KT | $197.6060 per EA | — |
Frequently Asked Questions
What is Leuprolide Acetate used to treat?
Leuprolide Acetate is used to treat breast neoplasms, endometrial neoplasms, endometriosis, infertility, leiomyoma and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.
When did Leuprolide Acetate become available as a generic?
FDA approved the first generic Leuprolide Acetate (ANDA) on Aug 4, 1998.
How much does Medicare spend on Leuprolide Acetate?
In 2024, Medicare Part D spent $177 million on Leuprolide Acetate across 41,000 claims for 16,000 beneficiaries.
How many Leuprolide Acetate products are on the market?
The Leuprolide Acetate drug market contains 14 NDCs from 10 manufacturers — 9 generic and 5 brand products.
What is the price range for Leuprolide Acetate?
NADAC reference prices for Leuprolide Acetate range from $197.6060 to $6516.2982 per EA — the most expensive product costs about 33× the cheapest.
Is generic Leuprolide Acetate cheaper than brand?
The average generic NADAC for Leuprolide Acetate is $205.5854 per EA, versus $3563.6719 for brand-labeled products — brand versions average about 17× the generic price.
Which manufacturers make Leuprolide Acetate?
10 manufacturers list Leuprolide Acetate in NADAC. Ranked by number of NDCs, the largest are AbbVie Inc. (5), VGYAAN Pharmaceuticals LLC (1), NorthStar Rx LLC (1), Sandoz Inc. (1), Amneal Pharmaceuticals LLC (1).
How has the price of Leuprolide Acetate changed recently?
Over the past 7 days, 0 Leuprolide Acetate NDCs rose and 2 fell, with a market-wide average change of -0.1%.